Association Between Results of a…
Conventional staging methods are inadequate to identify patients with stage II colon cancer (CC)...
Conventional staging methods are inadequate to identify patients with stage II colon cancer (CC)...
Current prognostic factors are poor at identifying patients at risk of disease recurrence after...
There is no method routinely used to predict response to anthracycline and cyclophosphamide–based chemotherapy...
Background: Previously we identified a DNA damage response deficient (DDRD) molecular subtype within breast cancer....
Radiotherapy is an effective treatment of intermediate/high-risk locally advanced prostate cancer, however,>30% of patients...
Background: Approximately 4–25% of patients with early prostate cancer develop disease recurrence following radical...